Experience of the use of octreotide for refractory gastrointestinal bleeding in a patient with Jarvik2000<sup>®</sup> left ventricular assist device.

导出 LinkOut

翻译打印收藏纠错

作者： Seiko,Nakajima-Doi ^[1] ; Osamu,Seguchi ^[1] ; Yasuhiro,Shintani ^[2] ; Tomoyuki,Fujita ^[3] ; Satsuki,Fukushima ^[3] ; Yorihiko,Matsumoto ^[3] ; Yuka,Eura ^[4] ; Koichi,Kokame ^[4] ; Shigeki,Miyata ^[5] ; Sachi,Matsuda ^[6] ; Hiroki,Mochizuki ^[1] ; Keiichiro,Iwasaki ^[1] ; Yuki,Kimura ^[1] ; Koichi,Toda ^[1] ; Yuto,Kumai ^[1] ; Kensuke,Kuroda ^[1] ; Takuya,Watanabe ^[1] ; Masanobu,Yanase ^[1] ; Junjiro,Kobayashi ^[2] ; Norihide,Fukushima ^[7]

作者单位： Department of Transplant Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe Shin-machi, Suita, 564-8565, Osaka, Japan. ^[1] Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan. ^[2] Department of Adult Cardiac Surgery, National Cerebral and Cardiovascular Center, Suita, Japan. ^[3] Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Suita, Japan. ^[4] Department of Transfusion Medicine, National Cerebral and Cardiovascular Center, Suita, Japan. ^[5] Department of Pharmacy, National Cerebral and Cardiovascular Center, Suita, Japan. ^[6] Department of Transplant Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe Shin-machi, Suita, 564-8565, Osaka, Japan. nori@ncvc.go.jp. ^[7]

关键词 Acquired von Willebrand syndrome Angiodysplasia Gastrointestinal bleeding Octreotide Ventricular assist device